Luo, N., Ballew, N. G., O’Brien, E., Greiner, M., Peterson, P., Hammill, B., … Fonarow, G. C. (2018). EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE. In Journal of the American College of Cardiology (Vol. 71, pp. A791–A791). Elsevier BV. https://doi.org/10.1016/s0735-1097(18)31332-9

Luo, Nancy, Nicholas G. Ballew, Emily O’Brien, Melissa Greiner, Pamela Peterson, Bradley Hammill, N Chantelle Hardy, et al. “EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE.” In Journal of the American College of Cardiology, 71:A791–A791. Elsevier BV, 2018. https://doi.org/10.1016/s0735-1097(18)31332-9.

Luo N, Ballew NG, O’Brien E, Greiner M, Peterson P, Hammill B, et al. EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE. In: Journal of the American College of Cardiology. Elsevier BV; 2018. p. A791–A791.

Luo, Nancy, et al. “EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE.” Journal of the American College of Cardiology, vol. 71, no. 11, Elsevier BV, 2018, pp. A791–A791. Crossref, doi:10.1016/s0735-1097(18)31332-9.

Luo N, Ballew NG, O’Brien E, Greiner M, Peterson P, Hammill B, Hardy NC, Laskey W, Heidenreich P, Chang C-L, Hernandez A, Curtis L, Mentz R, Fonarow GC. EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE. Journal of the American College of Cardiology. Elsevier BV; 2018. p. A791–A791.